Meuleman Philip, Libbrecht Louis, De Vos Rita, de Hemptinne Bernard, Gevaert Kris, Vandekerckhove Joël, Roskams Tania, Leroux-Roels Geert
Center for Vaccinology, Ghent University and Hospital, Ghent, Belgium.
Hepatology. 2005 Apr;41(4):847-56. doi: 10.1002/hep.20657.
A small animal model harboring a functional human liver cell xenograft would be a useful tool to study human liver cell biology, drug metabolism, and infections with hepatotropic viruses. Here we describe the repopulation, organization, and function of human hepatocytes in a mouse recipient and the infections with hepatitis B virus (HBV) and hepatitis C virus (HCV) of the transplanted cells. Homozygous urokinase plasminogen activator (uPA)-SCID mice underwent transplantation with primary human hepatocytes, and at different times animals were bled and sacrificed to analyze plasma and liver tissue, respectively. The plasma of mice that were successfully transplanted contained albumin and an additional 21 human proteins. Liver histology showed progressive and massive replacement of diseased mouse tissue by human hepatocytes. These cells were accumulating glycogen but appeared otherwise normal and showed no signs of damage or death. They formed functional bile canaliculi that connected to mouse canaliculi. Besides mature hepatocytes, human hepatic progenitor cells that were differentiating into mature hepatocytes could be identified within liver parenchyma. Infection of chimeric mice with HBV or HCV resulted in an active infection that did not alter the liver function and architecture. Electron microscopy showed the presence of viral and subviral structures in HBV infected hepatocytes. In conclusion, human hepatocytes repopulate the uPA(+/+)-SCID mouse liver in a very organized fashion with preservation of normal cell function. The presence of human hepatic progenitor cells in these chimeric animals necessitates a critical review of the observations and conclusions made in experiments with isolated "mature" hepatocytes. Supplementary material for this article can be found on the HEPATOLOGY website (http://www.interscience.wiley.com/jpages/0270-9139/suppmat/index.html).
携带功能性人肝细胞异种移植的小动物模型将是研究人肝细胞生物学、药物代谢以及嗜肝病毒感染的有用工具。在此,我们描述了小鼠受体中人肝细胞的再填充、组织化和功能,以及移植细胞的乙型肝炎病毒(HBV)和丙型肝炎病毒(HCV)感染情况。纯合子尿激酶型纤溶酶原激活剂(uPA)-SCID小鼠接受原代人肝细胞移植,在不同时间对动物进行采血和处死,分别分析血浆和肝组织。成功移植的小鼠血浆中含有白蛋白和另外21种人蛋白。肝脏组织学显示人肝细胞逐渐大量取代患病小鼠组织。这些细胞积累糖原,但在其他方面看起来正常,未显示损伤或死亡迹象。它们形成了与小鼠胆小管相连的功能性胆小管。除了成熟肝细胞外,在肝实质内还可鉴定出正在分化为成熟肝细胞的人肝祖细胞。用HBV或HCV感染嵌合小鼠导致了活跃感染,但未改变肝功能和结构。电子显微镜显示HBV感染的肝细胞中存在病毒和亚病毒结构。总之,人肝细胞以非常有组织的方式在uPA(+/+)-SCID小鼠肝脏中再填充,并保留正常细胞功能。这些嵌合动物中存在人肝祖细胞,这就需要对使用分离的“成熟”肝细胞进行的实验中所做的观察和结论进行批判性审视。本文的补充材料可在《肝脏病学》网站(http://www.interscience.wiley.com/jpages/0270-9139/suppmat/index.html)上找到。